[go: up one dir, main page]

DK3089667T3 - Offline-glucosestyring baseret på forudgående tidsrum - Google Patents

Offline-glucosestyring baseret på forudgående tidsrum Download PDF

Info

Publication number
DK3089667T3
DK3089667T3 DK15744078.5T DK15744078T DK3089667T3 DK 3089667 T3 DK3089667 T3 DK 3089667T3 DK 15744078 T DK15744078 T DK 15744078T DK 3089667 T3 DK3089667 T3 DK 3089667T3
Authority
DK
Denmark
Prior art keywords
time periods
management based
prior time
glucose management
offline
Prior art date
Application number
DK15744078.5T
Other languages
English (en)
Inventor
Edward R Damiano
Firas H El-Khatib
Original Assignee
Univ Boston
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Boston filed Critical Univ Boston
Application granted granted Critical
Publication of DK3089667T3 publication Critical patent/DK3089667T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/16804—Flow controllers
    • A61M5/16827—Flow controllers controlling delivery of multiple fluids, e.g. sequencing, mixing or via separate flow-paths
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H15/00—ICT specially adapted for medical reports, e.g. generation or transmission thereof
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M2005/14208—Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M2005/14288—Infusion or injection simulation
    • A61M2005/14296—Pharmacokinetic models
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0468—Liquids non-physiological
    • A61M2202/0486—Glucose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/07—Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A61M2205/3584—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using modem, internet or bluetooth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/502—User interfaces, e.g. screens or keyboards
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/005—Parameter used as control input for the apparatus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/20—Blood composition characteristics
    • A61M2230/201—Glucose concentration

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Primary Health Care (AREA)
  • Pathology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Optics & Photonics (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
DK15744078.5T 2014-01-31 2015-01-26 Offline-glucosestyring baseret på forudgående tidsrum DK3089667T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461933996P 2014-01-31 2014-01-31
PCT/US2015/012861 WO2015116524A1 (en) 2014-01-31 2015-01-26 Offline glucose control based on preceding periods

Publications (1)

Publication Number Publication Date
DK3089667T3 true DK3089667T3 (da) 2022-05-09

Family

ID=53757655

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15744078.5T DK3089667T3 (da) 2014-01-31 2015-01-26 Offline-glucosestyring baseret på forudgående tidsrum

Country Status (10)

Country Link
US (2) US10543313B2 (da)
EP (2) EP4091541A1 (da)
JP (1) JP6243546B2 (da)
CN (2) CN112515665B (da)
AU (2) AU2015211258A1 (da)
CA (1) CA2938078C (da)
DK (1) DK3089667T3 (da)
IL (1) IL246934B (da)
MX (2) MX373076B (da)
WO (1) WO2015116524A1 (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2755497T3 (es) 2010-10-31 2020-04-22 Univ Boston Sistema de control de glucosa en sangre
JP6243546B2 (ja) 2014-01-31 2017-12-06 トラスティーズ オブ ボストン ユニバーシティ 先行する期間に基づくオフライングルコースレベル制御
US9629901B2 (en) * 2014-07-01 2017-04-25 Bigfoot Biomedical, Inc. Glucagon administration system and methods
US9943645B2 (en) * 2014-12-04 2018-04-17 Medtronic Minimed, Inc. Methods for operating mode transitions and related infusion devices and systems
US10842934B2 (en) 2015-08-07 2020-11-24 Trustees Of Boston University Glucose control system with automatic adaptation of glucose target
EP3519997A1 (en) * 2016-09-30 2019-08-07 Novo Nordisk A/S Systems and methods for communicating a dose history representing an average and a variability of a distribution of medicament injections
US11147920B2 (en) * 2017-04-18 2021-10-19 Lifescan Ip Holdings, Llc Diabetes management system with automatic basal and manual bolus insulin control
ES2903174T3 (es) 2017-05-05 2022-03-31 Lilly Co Eli Control de bucle cerrado de glucosa fisiológica
GB201710822D0 (en) * 2017-07-05 2017-08-16 Zealand Pharma As Methods and medical uses relating to the treatment of hypoglycaemia
CN118217478A (zh) 2017-12-21 2024-06-21 益首药物治疗股份公司 生理葡萄糖的闭环控制
CN112236826B (zh) * 2018-05-04 2024-08-13 英赛罗公司 基于控制算法的药物输送系统的安全约束
JP2021528758A (ja) 2018-06-22 2021-10-21 イーライ リリー アンド カンパニー インスリンとプラムリンタイドの送達システム、方法、およびデバイス
US11071821B2 (en) * 2018-09-28 2021-07-27 Medtronic Minimed, Inc. Insulin infusion device with efficient confirmation routine for blood glucose measurements
US11957876B2 (en) 2019-07-16 2024-04-16 Beta Bionics, Inc. Glucose control system with automated backup therapy protocol generation
AU2020314752A1 (en) 2019-07-16 2022-02-24 Beta Bionics, Inc. Blood glucose control system
MX2022000670A (es) 2019-07-16 2022-05-20 Beta Bionics Inc Sistema de control de glucosa en sangre.
JP7730109B2 (ja) 2019-10-04 2025-08-27 ベータ バイオニクス，インコーポレイテッド 血糖制御システム
WO2021121622A1 (en) 2019-12-20 2021-06-24 Elekta Ab (Publ) Adaptive dose accumulation algorithm
WO2022140204A1 (en) 2020-12-21 2022-06-30 Beta Bionics, Inc. Medicament pumps and control systems thereof
USD1032623S1 (en) 2020-03-10 2024-06-25 Beta Bionics, Inc. Display screen with animated graphical user interface
US11278661B2 (en) 2020-03-10 2022-03-22 Beta Bionics, Inc. Infusion system and components thereof
USD1032624S1 (en) 2020-03-10 2024-06-25 Beta Bionics, Inc. Display screen with animated graphical user interface
US20220189603A1 (en) 2020-12-07 2022-06-16 Beta Bionics, Inc. Medicament pumps and control systems for managing glucose control therapy data of a subject
US20220265143A1 (en) 2020-12-07 2022-08-25 Beta Bionics, Inc. Ambulatory medicament pumps with selective alarm muting
US20220199218A1 (en) 2020-12-07 2022-06-23 Beta Bionics, Inc. Ambulatory medicament pump with integrated medicament ordering interface
US11497852B2 (en) 2020-12-21 2022-11-15 Beta Bionics, Inc. Ambulatory medicament device with power saving mode
US12465686B2 (en) 2021-03-25 2025-11-11 Beta Bionics, Inc. Emergency medicament dose control
CN113598763B (zh) * 2021-08-05 2024-10-18 重庆大学 一种基于mic-pca-narx校正算法的无创血糖检测装置及方法
WO2023070253A1 (en) * 2021-10-25 2023-05-04 Medtrum Technologies Inc. Closed-loop artificial pancreas insulin infusion control system
WO2025012775A1 (en) * 2023-07-07 2025-01-16 Jafar Adnan A multi-agent reinforcement learning-based decision support system for high fat meals and aerobic exercises for individuals with type 1 diabetes
WO2025117463A1 (en) * 2023-11-27 2025-06-05 Tandem Diabetes Care, Inc. Adaptive delivery profiles for automated insulin delivery treatment system
US20250360264A1 (en) * 2024-05-24 2025-11-27 Tandem Diabetes Care, Inc. Devices, systems, and methods for automated operation of infusion pumps with mobile devices

Family Cites Families (111)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6241704B1 (en) 1901-11-22 2001-06-05 Sims Deltec, Inc. Drug pump systems and methods
DK85633C (da) 1953-09-04 1958-06-02 Gestetner Ltd Duplikeringsmaskine.
US4280494A (en) 1979-06-26 1981-07-28 Cosgrove Robert J Jun System for automatic feedback-controlled administration of drugs
US4464170A (en) 1982-09-29 1984-08-07 Miles Laboratories, Inc. Blood glucose control apparatus and method
WO1989001794A1 (en) 1987-08-28 1989-03-09 Regents Of The University Of Minnesota Metabolic sensor for a drug delivery system
US5665065A (en) 1995-05-26 1997-09-09 Minimed Inc. Medication infusion device with blood glucose data input
US6554798B1 (en) 1998-08-18 2003-04-29 Medtronic Minimed, Inc. External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities
US6416471B1 (en) * 1999-04-15 2002-07-09 Nexan Limited Portable remote patient telemonitoring system
US6669663B1 (en) 1999-04-30 2003-12-30 Medtronic, Inc. Closed loop medicament pump
US6925393B1 (en) 1999-11-18 2005-08-02 Roche Diagnostics Gmbh System for the extrapolation of glucose concentration
DE10006044A1 (de) 2000-02-10 2001-08-16 Roche Diagnostics Gmbh Anordnung und Verfahren zur Dosierung eines die Blutglukose eines Patienten regulierenden Hormons
US6572542B1 (en) 2000-03-03 2003-06-03 Medtronic, Inc. System and method for monitoring and controlling the glycemic state of a patient
AU2001292946A1 (en) 2000-09-26 2002-04-08 Advantage 3D Llc Method and system for generation, storage and distribution of omni-directional object views
US20030073609A1 (en) 2001-06-29 2003-04-17 Pinkerton Thomas C. Enhanced pharmacokinetic profile of intradermally delivered substances
US6544212B2 (en) 2001-07-31 2003-04-08 Roche Diagnostics Corporation Diabetes management system
US6827702B2 (en) 2001-09-07 2004-12-07 Medtronic Minimed, Inc. Safety limits for closed-loop infusion pump control
GB0206792D0 (en) 2002-03-22 2002-05-01 Leuven K U Res & Dev Normoglycemia
US20040010207A1 (en) 2002-07-15 2004-01-15 Flaherty J. Christopher Self-contained, automatic transcutaneous physiologic sensing system
WO2005061041A1 (en) 2002-10-11 2005-07-07 Becton, Dickinson And Company Insulin delivery system with sensor
US7655618B2 (en) 2002-12-27 2010-02-02 Diobex, Inc. Compositions and methods for the prevention and control of insulin-induced hypoglycemia
WO2004084820A2 (en) 2003-03-19 2004-10-07 Harry Hebblewhite Method and system for determining insulin dosing schedules and carbohydrate-to-insulin ratios in diabetic patients
US20040253736A1 (en) * 2003-06-06 2004-12-16 Phil Stout Analytical device with prediction module and related methods
US7591801B2 (en) 2004-02-26 2009-09-22 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
DE102004011135A1 (de) 2004-03-08 2005-09-29 Disetronic Licensing Ag Verfahren und Vorrichtung zum Berechnen einer Bolusmenge
US7651845B2 (en) * 2004-05-13 2010-01-26 The Regents Of The University Of California Method and apparatus for glucose control and insulin dosing for diabetics
US7727147B1 (en) 2004-05-14 2010-06-01 Flint Hills Scientific Llc Method and system for implantable glucose monitoring and control of a glycemic state of a subject
EP1881786B1 (en) 2005-05-13 2017-11-15 Trustees of Boston University Fully automated control system for type 1 diabetes
US20060272652A1 (en) * 2005-06-03 2006-12-07 Medtronic Minimed, Inc. Virtual patient software system for educating and treating individuals with diabetes
US20060276771A1 (en) 2005-06-06 2006-12-07 Galley Paul J System and method providing for user intervention in a diabetes control arrangement
US7766829B2 (en) 2005-11-04 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
CN100446724C (zh) * 2005-11-28 2008-12-31 中国科学院电子学研究所 用于闭环胰岛素注射的无创血糖仪
US9392969B2 (en) 2008-08-31 2016-07-19 Abbott Diabetes Care Inc. Closed loop control and signal attenuation detection
JP4918285B2 (ja) * 2006-05-24 2012-04-18 シスメックス株式会社 生体器官の機能のシミュレーションシステム及びそのプログラム
WO2007149533A2 (en) * 2006-06-19 2007-12-27 Dose Safety System, method and article for controlling the dispensing of insulin
US20110054391A1 (en) * 2006-07-28 2011-03-03 Ward W Kenneth Analyte sensing and response system
US8721584B2 (en) 2006-11-02 2014-05-13 The University Of North Carolina At Chapel Hill Methods and systems for determining an intravenous insulin infusion rate to correct hyperglycemia of a patient, to maintain euglycemia of a patient, and to prevent hypoglycemia of a patient
US7654127B2 (en) 2006-12-21 2010-02-02 Lifescan, Inc. Malfunction detection in infusion pumps
US7946985B2 (en) 2006-12-29 2011-05-24 Medtronic Minimed, Inc. Method and system for providing sensor redundancy
US10154804B2 (en) * 2007-01-31 2018-12-18 Medtronic Minimed, Inc. Model predictive method and system for controlling and supervising insulin infusion
WO2008114254A1 (en) 2007-03-19 2008-09-25 Medingo Ltd. User interface for selecting bolus doses in a drug delivery device
EP1983456B1 (de) 2007-04-19 2013-08-14 F.Hoffmann-La Roche Ag Verfahren zum Einstellen eines Basalratenprofils für eine Insulinpumpe
US20080269714A1 (en) 2007-04-25 2008-10-30 Medtronic Minimed, Inc. Closed loop/semi-closed loop therapy modification system
US20100145262A1 (en) 2007-05-03 2010-06-10 Novo Nordisk A/S Safety system for insulin delivery advisory algorithms
US7751907B2 (en) 2007-05-24 2010-07-06 Smiths Medical Asd, Inc. Expert system for insulin pump therapy
ES2576639T3 (es) 2007-06-20 2016-07-08 F.Hoffmann-La Roche Ag Método y dispositivo para evaluar la relación de hidratos de carbono con respecto a insulina
EP4276851A3 (en) 2007-06-21 2024-01-24 University Of Virginia Patent Foundation Lqg artificial pancreas control system and related method
DK2167168T3 (da) 2007-06-25 2017-06-06 Hoffmann La Roche Individualiseret basalt insulinindgivelsessystem
CA2687562C (en) 2007-06-27 2015-11-24 F. Hoffmann-La Roche Ag System and method for developing patient specific therapies based on modeling of patient physiology
CN101821741B (zh) * 2007-06-27 2013-12-04 霍夫曼-拉罗奇有限公司 用于被调用事件的医学诊断、治疗和预后系统及其方法
JP5410284B2 (ja) * 2007-09-07 2014-02-05 テルモ株式会社 血糖値測定装置及び処方情報処理方法
US8377031B2 (en) 2007-10-23 2013-02-19 Abbott Diabetes Care Inc. Closed loop control system with safety parameters and methods
WO2009059187A1 (en) 2007-11-02 2009-05-07 University Of Virginia Patent Foundation Predictive control based system and method for control of insulin delivery in diabetes using glucose sensing
US8290559B2 (en) 2007-12-17 2012-10-16 Dexcom, Inc. Systems and methods for processing sensor data
US20090164239A1 (en) 2007-12-19 2009-06-25 Abbott Diabetes Care, Inc. Dynamic Display Of Glucose Information
US20090177154A1 (en) 2008-01-08 2009-07-09 Michael Blomquist Insulin pump with convenience features
US20090177142A1 (en) 2008-01-09 2009-07-09 Smiths Medical Md, Inc Insulin pump with add-on modules
US8185412B1 (en) * 2008-03-28 2012-05-22 Mahesh Harpale Method and apparatus for chronic care treatment control with custom named-type factors and user estimation error correction
WO2009146119A2 (en) 2008-04-04 2009-12-03 Hygieia, Inc. System for optimizing a patient's insulin dosage regimen
CN102077108B (zh) * 2008-04-28 2015-02-25 康奈尔大学 分子mri中的磁敏度精确量化
CN201186082Y (zh) * 2008-05-05 2009-01-28 王安宇 胰岛素、葡萄糖智能输入装置
US7959598B2 (en) * 2008-08-20 2011-06-14 Asante Solutions, Inc. Infusion pump systems and methods
US8622988B2 (en) 2008-08-31 2014-01-07 Abbott Diabetes Care Inc. Variable rate closed loop control and methods
US8527208B2 (en) * 2008-11-17 2013-09-03 Roche Diagnostics International Ag Prandial blood glucose excursion optimization method via computation of time-varying optimal insulin profiles and system thereof
EP2393415B1 (en) * 2009-02-04 2015-11-25 Sanofi-Aventis Deutschland GmbH Medical system and method for providing information for glycemic control
JP5783912B2 (ja) 2009-02-04 2015-09-24 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 血糖応答情報に基づく血糖コントロールを提供するための医療システム及び方法
US8562587B2 (en) 2009-02-25 2013-10-22 University Of Virginia Patent Foundation CGM-based prevention of hypoglycemia via hypoglycemia risk assessment and smooth reduction of insulin delivery
CA2752637A1 (en) 2009-02-26 2010-09-02 Eran Atlas Method and system for automatic monitoring of diabetes related treatments
US20100256466A1 (en) 2009-04-02 2010-10-07 Avraham Shekalim Metabolite Management System
JP2012527981A (ja) 2009-05-29 2012-11-12 ユニバーシティ オブ バージニア パテント ファウンデーション 糖尿病の開ループおよび閉ループ制御のためのシステムコーディネータおよびモジュールアーキテクチャ
FI3936032T3 (fi) 2009-07-23 2024-08-14 Abbott Diabetes Care Inc Glukoositasojen fysiologiseen säätelyyn liittyvien tietojen reaaliaikainen hallinta
WO2011014851A1 (en) 2009-07-31 2011-02-03 Abbott Diabetes Care Inc. Method and apparatus for providing analyte monitoring system calibration accuracy
US20120245556A1 (en) 2009-09-01 2012-09-27 University Of Virginia Patent Foundation System, Method and Computer Program Product For Adjustment of Insulin Delivery in Diabetes Using Nominal Open-Loop Profiles
DK2477613T3 (da) 2009-09-18 2017-11-13 Hoffmann La Roche Anordninger, systemer og fremgangsmåder til kvantificering af bolusdoser ifølge brugerparametre
KR20120102048A (ko) * 2009-09-30 2012-09-17 모르 리서치 애플리케이션즈 리미티드 인슐린 전달의 관리를 위한 모니터링 장치
US8690820B2 (en) 2009-10-06 2014-04-08 Illinois Institute Of Technology Automatic insulin pumps using recursive multivariable models and adaptive control algorithms
US20120277723A1 (en) 2009-11-04 2012-11-01 Aimedics Pty Ltd System and method for the integration of fused-data hypoglycaemia alarms into closed-loop glycaemic control systems
CA2787942A1 (en) * 2010-01-25 2011-07-28 Ventria Bioscience Methods & compositions for improving protein production
WO2011100624A1 (en) * 2010-02-11 2011-08-18 The Regents Of The University Of California Systems, devices and methods to deliver biological factors or drugs to a subject
US8579879B2 (en) * 2010-02-19 2013-11-12 Medtronic Minimed, Inc. Closed-loop glucose control startup
CA2790912A1 (en) * 2010-02-25 2011-09-01 Lifescan Scotland Limited Analyte testing method and system with safety warnings for insulin dosing
EP3593711B8 (en) 2010-03-26 2021-07-28 University Of Virginia Patent Foundation System for improving the accuracy of glucose sensors using insulin delivery observation in diabetes
US10561785B2 (en) * 2010-06-22 2020-02-18 Medtronic Minimed, Inc. Method and/or system for closed-loop control of glucose to a treatment range
CN102346961A (zh) * 2010-07-29 2012-02-08 鸿富锦精密工业（深圳）有限公司 电子设备
ES2755497T3 (es) 2010-10-31 2020-04-22 Univ Boston Sistema de control de glucosa en sangre
US9445757B2 (en) 2010-12-29 2016-09-20 Medtronic Minimed, Inc. Glycemic health metric determination and application
US9913599B2 (en) * 2011-02-11 2018-03-13 Abbott Diabetes Care Inc. Software applications residing on handheld analyte determining devices
US10610154B2 (en) 2011-06-23 2020-04-07 University Of Virginia Patent Foundation Unified platform for monitoring and control of blood glucose levels in diabetic patients
GB2493712B (en) 2011-08-12 2014-07-02 Gene Onyx Ltd Insulin pump
US10694983B2 (en) 2012-01-19 2020-06-30 Medtronic Minimed, Inc. Method and/or system for assessing a patient's glycemic response
US9238100B2 (en) 2012-06-07 2016-01-19 Tandem Diabetes Care, Inc. Device and method for training users of ambulatory medical devices
US9662445B2 (en) 2012-08-30 2017-05-30 Medtronic Minimed, Inc. Regulating entry into a closed-loop operating mode of an insulin infusion system
US9901677B2 (en) 2012-10-16 2018-02-27 Bigfoot Biomedical, Inc. Infusion pump system and methods
US9486578B2 (en) 2012-12-07 2016-11-08 Animas Corporation Method and system for tuning a closed-loop controller for an artificial pancreas
US9907909B2 (en) 2012-12-20 2018-03-06 Animas Corporation Method and system for a hybrid control-to-target and control-to-range model predictive control of an artificial pancreas
US9351670B2 (en) 2012-12-31 2016-05-31 Abbott Diabetes Care Inc. Glycemic risk determination based on variability of glucose levels
US10507284B2 (en) 2013-01-14 2019-12-17 The Regents Of The University Of California Daily periodic target-zone modulation in the model predictive control problem for artificial pancreas for type I diabetes applications
US9492608B2 (en) 2013-03-15 2016-11-15 Tandem Diabetes Care, Inc. Method and device utilizing insulin delivery protocols
EP3030140B1 (en) 2013-08-05 2019-06-19 Hygieia, Inc. Systems and devices for alleviating glucotoxicity and restoring pancreatic beta-cell function in advanced diabetes mellitus
EP2851823A1 (en) 2013-09-20 2015-03-25 Sanofi-Aventis Deutschland GmbH Data management unit for supporting health control
JP6243546B2 (ja) 2014-01-31 2017-12-06 トラスティーズ オブ ボストン ユニバーシティ 先行する期間に基づくオフライングルコースレベル制御
US9486580B2 (en) 2014-01-31 2016-11-08 Aseko, Inc. Insulin management
US9399096B2 (en) 2014-02-06 2016-07-26 Medtronic Minimed, Inc. Automatic closed-loop control adjustments and infusion systems incorporating same
EP3154607B1 (en) 2014-06-10 2023-12-20 Insulet Corporation Insulin delivery systems and methods
CN104667368B (zh) 2015-03-06 2017-08-15 上海交通大学 控制与计算分离的胰岛素泵动态控制实现方法
CN104667379B (zh) 2015-03-06 2017-08-15 上海交通大学 动态闭环控制的胰岛素泵
US10569016B2 (en) 2015-12-29 2020-02-25 Tandem Diabetes Care, Inc. System and method for switching between closed loop and open loop control of an ambulatory infusion pump
CN108495665B (zh) 2016-01-14 2021-04-09 比格福特生物医药公司 调整胰岛素输送速率
US20200254240A1 (en) 2016-05-15 2020-08-13 Biolinq, Inc. Devices and Methods For The Incorporation Of A Microneedle Array Analyte-Selective Sensor Into An Infusion Set, Patch Pump, Or Automated Therapeutic Delivery System
WO2018011766A1 (en) 2016-07-15 2018-01-18 Universität Bern Estimation of insulin based on reinforcement learning
EP3568859B1 (en) 2017-01-13 2025-12-10 Insulet Corporation Insulin delivery methods, systems and devices
CN112236826B (zh) 2018-05-04 2024-08-13 英赛罗公司 基于控制算法的药物输送系统的安全约束

Also Published As

Publication number Publication date
JP2017511911A (ja) 2017-04-27
EP3089667A1 (en) 2016-11-09
AU2017251868A1 (en) 2017-11-16
CA2938078A1 (en) 2015-08-06
IL246934A0 (en) 2016-09-29
JP6243546B2 (ja) 2017-12-06
WO2015116524A1 (en) 2015-08-06
AU2015211258A1 (en) 2016-08-11
EP4091541A1 (en) 2022-11-23
CN112515665A (zh) 2021-03-19
USRE50075E1 (en) 2024-08-13
CN106456064A (zh) 2017-02-22
US20160331898A1 (en) 2016-11-17
CA2938078C (en) 2019-06-11
MX2020004660A (es) 2020-07-24
CN112515665B (zh) 2024-03-29
MX373076B (es) 2020-07-06
EP3089667B1 (en) 2022-04-13
CN106456064B (zh) 2020-11-27
IL246934B (en) 2021-05-31
EP3089667A4 (en) 2017-09-13
US10543313B2 (en) 2020-01-28
AU2017251868B2 (en) 2019-07-11
MX2016009787A (es) 2017-02-22

Similar Documents

Publication Publication Date Title
DK3089667T3 (da) Offline-glucosestyring baseret på forudgående tidsrum
EP3780515C0 (en) CUSTOMER MANAGEMENT
PL3560953T3 (pl) Komórka
IL249546B (en) One way display
PL3151327T3 (pl) Roztwór elektrolitu
BR112017012364A2 (pt) pré-tratamento rápido.
DK3129563T3 (da) Bærestruktur
DK3193667T3 (da) Modulhylde
DK3001700T3 (da) Positioneret høresystem
FR3023988B3 (fr) .
FI20155989A7 (fi) Sensoripohjainen kontekstin hallinnointi
FR3023171B1 (fr) Autoinjecteur.
DE202014104222U8 (de) Steckverbinder
FR3023170B1 (fr) Autoinjecteur.
DK3412700T3 (da) Forbindelser
DK3009576T3 (da) Vådrumsmodul
EP3171776C0 (de) Abbildungsanordnung
DE112015001587A5 (de) Lageranordnung
DK3001076T3 (da) Tilbageløbsforhindrer
FR3020631B1 (fr) Cabestan
TH1601003177A (th) ซับสเทรทที่มีสภาพเคลือบได้ที่ปรับปรุงให้ดีขึ้นแล้ว
TH1601005233A (th) สารเอนไซม์
ES1116480Y (es) Colmena de estructura abatible
CL2015001474S1 (es) Estante
CL2015001475S1 (es) Estante